Blog Posts

Supreme Court ‘Chevron’ Ruling Increases Pressure on Congress to Act on 340B But Unlikely to Immediately Impact Program Oversight

The Supreme Court further limited federal agencies' regulatory authority, but it is unlikely to significantly effect program oversight in the short-term.
A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Patient Turned Advocate: David Alexander Discusses 340B

SPONSORED CONTENT

David Alexander currently serves as AIDS Health Care Foundation’s (AHF) Advocacy Mobilizer in Columbia, South Carolina. He is constantly striving to make the world a better place. He was a patient at a South Carolina clinic when he came under the care of nurse

Read More »

Viatris Becomes 37th Manufacturer to Place Restrictions on 340B Contract Pharmacy Use; Policy Applies to Hospitals and Health Centers

Drug manufacturer Viatris has placed 340B contract pharmacy restrictions on hospitals and community health centers.
Canonsburg, Penn.-based Viatris yesterday became the 37th drugmaker to restrict the shipment of 340B-priced drugs in the contract pharmacy setting. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More Drugmakers Exempt States from Contract Pharmacy Restrictions as Four New State Laws Take Effect

Four major drug manufacturers announced they will fully or partially exempt covered entities in certain states from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Delaware Legislature Passes Anti-Discrimination Protections for 340B Providers from PBMs but Drug Manufacturer Restrictions Remain

Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday.
Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Urge Federal Court to Uphold Maryland’s 340B Contract Pharmacy Access Law

American Hospital Association logo
The American Hospital Association (AHA), 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers urged a federal judge to reject Novartis’ attempt to block Maryland’s new 340B contract pharmacy access law.
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals in Texas and Other States Sue HHS Over DSH Calculation Changes That Impact 340B Eligibility

Dozens of hospitals in Texas and other states have filed suit against HHS to block a rule that they say lowers their disproportionate share hospital adjustment percentage and could result in a loss of 340B discounts.
Dozens of hospitals in Texas and other states have filed suits against Department of Health and Human Services (HHS) Secretary [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Verity Panel Discussion: 340B Outlook from Washington, D.C. & the States

SPONSORED CONTENT

Join us for coffee and listen to a panel of 340B national leaders for a discussion that promises to bring you unique and candid viewpoints on the latest 340B developments.

Read More »

New York Times Sues HRSA To Release 340B Data, Communications Between Office of Pharmacy Affairs and Apexus Leaders; Information Could Be Released Soon

The New York Times has filed suit in the U.S. District Court for the Southern District of New York against the Health Resources and Services Administration to obtain an order requiring the production of 340B-related records requested in November 2023 under the Freedom of Information Act.
The New York Times has sued the federal agency tasked with overseeing the 340B program to force the release of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Days Before New Laws Go Into Effect, GSK, Pfizer Exempt Additional States from Contract Pharmacy Restrictions

GlaxoSmithKline wordmark and GSK logo on a building
GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.
Correction, Thursday, July 27, 2024, 7:00 p.m. EDT—The original version of this article mistakenly said Minnesota’s contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live